Replaceable Aerogen Solo & Ultra
Aerogen is a silent, high performance vibrating mesh drug delivery device that can cross multiple modalities for ventilated and non-ventilated patients. By delivering more aerosol than any other device, Aerogen can improve patient outcomes at any phase of the patient’s care.
***Please note that this product can not work without a USB controller. USB Controller is not included in this replacement product.***
AEROGEN SOLO
Aerogen Solo – the world leader in acute care aerosol drug delivery
Discover how the Aerogen Solo can support aerosol drug respiratory therapy at every stage of a patient's respiratory journey: during invasive mechanical ventilation (IMV) and non-
invasive supports such as non-invasive ventilation (NIV), high-flow (HF) therapies and when self-ventilating (SV).Aerogen Solo Key Featurs:
• Refill medication without breaking the circuit
• Can be used with all medications for inhalation
• No heating or degradation of medication
• Minimal residual volume (<0.1ml for 3ml dose)
• High speed of delivery
• Does not affect ventilator parameters
• Suitable for solutions, suspensions, proteins & peptides
• Can be placed at the wye
• No noiseAEROGEN ULTRA
Aerogen Ultra – a global leader in aerosol drug delivery
Discover how the Aerogen Ultra – a handheld device – can be used in conjunction with the Aerogen Solo to deliver inhalation treatment either post-ventilation as part of the weaning process or during exacerbations.
Global market presence in 75+ countries worldwideAerogen Ultra Key Features:
• Oxygen port enables optional delivery of oxygen.
• An ergonomic valved mouthpiece controls the flow of air through the chamber to facilitate aerosol drug delivery.
• Aerogen Ultra, optional delivery of oxygen
•Innovative chamber design provides an aerosol reservoir intended for optimal drug deliveryEffectiveness
Aerogen Ultra facilitates effective medication delivery during self-ventilation.
In studies, bronchodilator administration via the Aerogen Ultra was associated with:
• 6x more medication delivered to the lungs during self-ventilation versus a jet nebuliser3
• Significantly less medication left in the cup versus other nebulisers.Patient Care
Aerogen Ultra improves patient care in response to aerosolised medication.
In studies, when compared with jet nebulisers, bronchodilator administration via Aerogen Ultra was associated with:• Significantly fewer treatments and significantly less time required to achieve symptom control
Across all patients in an emergency department:
• 30% relative reduction in hospital admission rates6
• 85% of patients achieving symptom control with one 2.5 mg salbutamol dose6
•37-minute reduction in ED median length of stay.Workflow
Aerogen simplifies the workflow.
• Aerogen is intended for the aerosolisation of any physician-prescribed solutions for inhalation.• One system used throughout a patient's respiratory journey (IMV, NIV, HF, self-ventilating),2 supporting continuity of care.
• Virtually silent delivery, keeping a calm environment for your patients.
NAPPY CODE:
567375002 / 238973001